Science AI Journal
Biochemistry, Genetics and Molecular Biology · Research topic

Open research questions in Advanced Glycation End Products research

112 unresolved questions extracted from the limitations and future-work sections of 256 Advanced Glycation End Products research papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • The lack of studies on the antidiabetic effect of folklore powders. The need for alternative treatments for Type 2 diabetes mellitus. The potential for synergistic outcomes from the combination of folklore drugs.

    EFFECT OF A FOLKLORE POWDER ON HYPERGLYACEMIC RATS IN COMPARISON WITH GLIBENCLAMIDE · 2026 · DOI

  • Future therapeutic strategies may require selective modulation of pathogenic HMGB1 signaling - Research on the specific roles of many HMGB1 PTMs in NPC remains incompletely characterized

    HMGB1 Post-Translational Modifications in Epstein–Barr Virus-Associated Nasopharyngeal Carcinoma: Current Evidence, Emerging Mechanistic Concepts, and Unresolved Questions · 2026 · DOI

  • The specific roles of many HMGB1 PTMs in NPC remain incompletely characterized - The mechanisms by which HMGB1 PTMs regulate its biological activities are not fully understood - The therapeutic potential of targeting HMGB1 PTMs in NPC is unclear

    HMGB1 Post-Translational Modifications in Epstein–Barr Virus-Associated Nasopharyngeal Carcinoma: Current Evidence, Emerging Mechanistic Concepts, and Unresolved Questions · 2026 · DOI

  • The study was not powered to examine the effect of ARO-RAGE on asthma exacerbation rate, - Given the known variability in key pulmonary function test (PFT) readouts such as FEV1 in patients with obstructive airway disease (>20%), these measures as efficacy endpoints lack statistical power to detect an effect in a study this size

    Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial · 2026 · DOI

  • The impact of ARO-RAGE on inflammatory pathways will be explored in future clinical trials, - Further investigation into the therapeutic potential of ARO-RAGE is warranted

    Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial · 2026 · DOI

  • The detection and quantification of Maillard reaction products are challenging due to their high molecular weight, structural diversity, and non-volatility. The paper identifies the need for reliable methods to accurately determine the structure of Maillard reaction products. The paper highlights the challenge of balancing the antioxidant properties of Maillard reaction products with the safety concerns of potential harmful byproducts.

    Antioxidant Activity of Maillard Reaction Products in Dairy Products: Formation, Influencing Factors, and Applications · 2026 · DOI

  • Melanoidins pose challenges for direct quantification and structural characterization due to its high molecular weight, structural diversity, and non-volatility, - Traditional detection methods for melanoidins lack specificity, - No reliable method currently exists for accurate structure of melanoidins

    Antioxidant Activity of Maillard Reaction Products in Dairy Products: Formation, Influencing Factors, and Applications · 2026 · DOI

  • One challenge is the complexity of the interplay between metabolic syndrome, inflammation, and eye diseases. Another challenge is the need for targeted therapies to manage both systemic metabolic abnormalities and their ocular complications.

    Link Between Metabolic Syndrome, Inflammation, and Eye Diseases · 2025 · DOI

  • detailed investigation of antioxidative antidiabetic drugs and substances is needed, - further research on the correlation between atherogenesis and the Nrf2/Keap1 pathway is required, - the effects of treatments for diabetes on the Nrf2 pathway of the heart, kidney, and liver systems need to be studied

    Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities · 2024 · DOI

  • There is a limited understanding of the role of the Nrf2 pathway in diabetic comorbidities. There is a need to identify potential targets for the treatment of diabetes and its associated comorbidities. The paper aims to address this gap by reviewing the current understanding of the Nrf2 pathway and its role in diabetic comorbidities.

    Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities · 2024 · DOI

  • Chronic inflammation is a complex process that underlies many skin diseases. The RAGE pathway is involved in multiple signaling pathways, making it challenging to target. Further research is needed to fully understand the role of RAGE in skin diseases and to develop effective therapeutic options.

    The RAGE Pathway in Skin Pathology Development: A Comprehensive Review of Its Role and Therapeutic Potential · 2024 · DOI

  • The literature on the RAGE pathway in AD is limited, - RAGE expression has only been assessed using immunohistochemistry (IHC), - It remains unclear whether the isoform detected was fl-RAGE

    The RAGE Pathway in Skin Pathology Development: A Comprehensive Review of Its Role and Therapeutic Potential · 2024 · DOI

  • Consumption of ultra-processed food (UPF) is increasing and is causally linked with noncommunicable disease onset, however specific compounds within UPFs that influence disease risk remain poorly defined.

    Ultra processed microbiome: Effects of dietary Stable Carbonyl adducts (SCars) on developing microbiota of mice · 2026 · DOI

  • Dietary SCars have been associated with metabolic dysfunction; however, their impact on microbiome composition during windows of developmental vulnerability has not been well studied.

    Ultra processed microbiome: Effects of dietary Stable Carbonyl adducts (SCars) on developing microbiota of mice · 2026 · DOI

  • Future research should focus on delineating the precise mechanisms linking these diseases as well as exploring targeted interventions that address both metabolic and ocular health.

    Link Between Metabolic Syndrome, Inflammation, and Eye Diseases · 2025 · DOI

  • However, its molecular mechanisms in reducing oxidative stress in diabetic cataract (DC) remain unclear.

    Protocatechualdehyde attenuates oxidative stress in diabetic cataract via GLO1-mediated inhibition of AGE/RAGE glycosylation · 2025 · DOI

  • However, the cellular and molecular basis of such an association remains poorly understood.

    High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury · 2025 · DOI

  • Future clinical studies are warranted to validate these findings and facilitate translation into human therapeutic applications.

    Innovative pH-responsive alginate-coated rosuvastatin-loaded chitosan nanoparticles: a targeted approach to inhibiting HMGB1-activated RAGE/TLR4-NFκB signaling in colonic inflammation in rats · 2025 · DOI

  • Previous studies indicated that disrupted lipid homeostasis can lead to lipid peroxidation damage and inflammation, yet the underlying mechanisms remain unclear.

    ACSL1 Aggravates Thromboinflammation by LPC/LPA Metabolic Axis in Hyperlipidemia Associated Myocardial Ischemia‐Reperfusion Injury · 2025 · DOI

  • However, its pathogenesis remains incompletely understood, hindering the development of effective treatments.

    Targeting programmed cell death pathways: emerging therapeutic strategies for diabetic kidney disease · 2025 · DOI

  • However, the relationship between HGI and short-term mortality risk in patients with a first diagnosis of acute myocardial infarction (AMI) remains unclear.

    Association between different hemoglobin glycation index and prognosis in patients with a first diagnosis of acute myocardial infarction: a retrospective study based on the MIMIC-IV database · 2025 · DOI

  • However, the effect of HMGB1 on PD-L1 expression in non-small cell lung cancer remains unclear.

    HMGB1 inhibits the IFN-γ–induced PD-L1 expression in NSCLC · 2025 · DOI

  • But how aging renders both humans and mice more vulnerable to the detrimental effect of fatty foods is not completely known.

    Age-related decline in HMGB1-neutralizing IgM autoantibody response impairs resistance to high-fat diet in mice · 2025 · DOI

  • Currently, most existing mitigation strategies focus on inhibiting harmful products, while research on the synergistic optimization of color and flavor remains insufficient.

    Maillard Reaction in Flour Product Processing: Mechanism, Impact on Quality, and Mitigation Strategies of Harmful Products · 2025 · DOI

  • Future research should focus on elucidating the molecular mechanisms of reaction pathways, understanding multi-factor synergistic effects, and developing composite regulation technologies to balance the sensory quality and safety of flour products.

    Maillard Reaction in Flour Product Processing: Mechanism, Impact on Quality, and Mitigation Strategies of Harmful Products · 2025 · DOI

Most-cited papers in Advanced Glycation End Products research

Most recent work

Find a gap in your own Advanced Glycation End Products research sub-topic

This page shows what the Advanced Glycation End Products research literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Biochemistry, Genetics and Molecular Biology

Gut microbiota and health
1,988 open questions
Single-cell and spatial transcriptomics
739 open questions
Extracellular vesicles in disease
551 open questions
Antibiotic Resistance in Bacteria
540 open questions
Genetic Associations and Epidemiology
535 open questions
Inflammatory Bowel Disease
499 open questions
RNA modifications and cancer
423 open questions
Mitochondrial Function and Pathology
419 open questions
112 open questions have been extracted from the limitations and future-work passages of 256 Advanced Glycation End Products research papers in our 4.5M-paper local library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.